These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22582938)

  • 1. Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies.
    Yang A; Ma J; Wu M; Qin W; Zhao B; Shi Y; Jin Y; Xie Y
    Leuk Lymphoma; 2012 Dec; 53(12):2465-73. PubMed ID: 22582938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
    Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
    Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia.
    Harada M; Pokrovskaja-Tamm K; Söderhäll S; Heyman M; Grander D; Corcoran M
    Leuk Lymphoma; 2012 Oct; 53(10):2041-50. PubMed ID: 22475310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8‑bromo‑7‑methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin‑sensitive and resistant ovarian cancer cells.
    Ding Q; Chen Y; Zhang Q; Guo Y; Huang Z; Dai L; Cao S
    Mol Med Rep; 2015 Oct; 12(4):5100-8. PubMed ID: 26151347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis.
    Molitoris JK; McColl KS; Distelhorst CW
    Mol Endocrinol; 2011 Mar; 25(3):409-20. PubMed ID: 21239610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
    Hall CP; Reynolds CP; Kang MH
    Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction by MEK inhibition in human lung cancer cells is mediated by Bim.
    Meng J; Fang B; Liao Y; Chresta CM; Smith PD; Roth JA
    PLoS One; 2010 Sep; 5(9):e13026. PubMed ID: 20885957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
    Heidari N; Miller AV; Hicks MA; Marking CB; Harada H
    Cell Death Dis; 2012 Jul; 3(7):e349. PubMed ID: 22825467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis.
    Guo L; Xu J; Qi J; Zhang L; Wang J; Liang J; Qian N; Zhou H; Wei L; Deng L
    J Cell Sci; 2013 Feb; 126(Pt 4):978-88. PubMed ID: 23264746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells.
    Guan H; Song L; Cai J; Huang Y; Wu J; Yuan J; Li J; Li M
    PLoS One; 2011; 6(5):e19946. PubMed ID: 21625639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.
    Kfir-Erenfeld S; Haggiag N; Biton M; Stepensky P; Assayag-Asherie N; Yefenof E
    Oncotarget; 2017 Jan; 8(1):472-489. PubMed ID: 27888798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.
    Yamamura Y; Lee WL; Inoue K; Ida H; Ito Y
    J Biol Chem; 2006 Feb; 281(8):5267-76. PubMed ID: 16373335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.
    Carbajo-Pescador S; Steinmetz C; Kashyap A; Lorenz S; Mauriz JL; Heise M; Galle PR; González-Gallego J; Strand S
    Br J Cancer; 2013 Feb; 108(2):442-9. PubMed ID: 23257900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced apoptosis requires FOXO3A activity.
    Ma J; Xie Y; Shi Y; Qin W; Zhao B; Jin Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):894-8. PubMed ID: 18957280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
    Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.